Mangoceuticals annual operating margin
2022
2023
2024
2025
Mangoceuticals Operating Margin Growth & History (MGRX)
Mangoceuticals's operating margin was −3,954.28% for fiscal 2025.
View full Mangoceuticals company overviewMangoceuticals annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −3,954.28% | −2659.86 pp |
| 2024 | 2024-12-31 | −1,294.42% | −34.14 pp |
| 2023 | 2023-12-31 | −1,260.28% | +21019.41 pp |
| 2022 | 2022-12-31 | −22,279.70% | — |
Mangoceuticals quarterly operating margin
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −1,502.45% | +1631.52 pp |
| Q1 2026 | 2026-03-31 | −4,606.75% | −420.00 pp |
| Q4 2025 | 2025-12-31 | −683.08% | +910.94 pp |
| Q3 2025 | 2025-09-30 | −8,953.45% | −7635.24 pp |
| Q2 2025 | 2025-06-30 | −3,133.98% | −1804.85 pp |
| Q1 2025 | 2025-03-31 | −4,186.75% | −3080.88 pp |
| Q4 2024 | 2024-12-31 | −1,594.02% | −543.16 pp |
| Q3 2024 | 2024-09-30 | −1,318.21% | −584.22 pp |
| Q2 2024 | 2024-06-30 | −1,329.13% | +293.86 pp |
| Q1 2024 | 2024-03-31 | −1,105.87% | +1434.91 pp |
| Q4 2023 | 2023-12-31 | −1,050.87% | — |
| Q3 2023 | 2023-09-30 | −733.99% | — |
| Q2 2023 | 2023-06-30 | −1,622.99% | — |
| Q1 2023 | 2023-03-31 | −2,540.78% | — |
Mangoceuticals operating margin trends
Between the periods ended 2022-12-31 and 2025-12-31, Mangoceuticals's operating margin increased from −22,279.70% to −3,954.28%, a change of +18325.42 percentage points. The latest reported quarter, Q2 2026, shows −1,502.45%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Mangoceuticals source filings ↗